Serotonin syndromes comes up a lot in critical care medicine.  Sometimes we are admitting patients because of a primary diagnosis of serotonin syndrome.  Other times we are afraid of causing serotonin syndrome ourselves, due to polypharmacy.  In both scenarios, there may be uncertainty regarding whether or not a patient has serotonin syndrome.

This chapter explores the causes, presentation, and treatment of serotonin syndrome.  There are precisely zero human RCTs on the treatment of serotonin syndrome, so this leaves considerable room for debate.  A treatment algorithm is proposed which I believe is reasonable (while fully acknowledging that there are numerous other potential strategies to treat this disease and no conclusive evidence regarding which is best).

• The IBCC chapter is located here.

• The podcast & comments are below.

Follow us on iTunes

• Author
• Recent Posts

Social Me

Josh Farkas

Josh is the creator of PulmCrit.org. He is an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.

Social Me

Latest posts by Josh Farkas (see all)

• IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
• PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021
• PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19? - January 12, 2021